An interventional study of 1ml of local anesthetics (1% Lidocaine) were injected into the subcutaneous layer. and 1ml of a local anesthetics (1% idocaine) are first injected into the subcutaneous layer, followed by 3~4ml of local anesthetics to the muscle layer along the expected needle pathway. in Lumbar Radiculopathy Due to Spinal Nerve Compression, sponsored by Yonsei University. Completed at 1 site in Korea, Republic of. Open to participants aged 20 Years to 80 Years. Per ClinicalTrials.gov, last updated 2019-01-11.
Sponsored by Yonsei University · Not applicable, Interventional, and Supportive care
Lumbar Transforaminal Epidural Injection is helpful for the treatment of lumbosacral radicular pain. But needle handling during the procedure may cause pain and discomfort to the patient. At the local skin anesthesia step, local anesthetics injection to the muscle layer along the needle pathway as well as the subcutaneous layer may reduce the procedural pain. In addition, it can reduce the injection site pain that may occur after the procedure.
Exclusion Criteria:
Procedure: 1ml of local anesthetics (1% Lidocaine) were injected into the subcutaneous layer. · Drug: 1% Lidocaine
Procedure: 1ml of a local anesthetics (1% idocaine) are first injected into the subcutaneous layer, followed by 3~4ml of local anesthetics to the muscle layer along the expected needle pathway. · Drug: 1% Lidocaine
1) In group A, 1ml of local anesthetics (1% Lidocaine) were injected into the subcutaneous layer.
2) In group B, 1ml of a local anesthetics (1% Lidocaine) are first injected into the subcutaneous layer, followed by 3\~4ml of local anesthetics to the muscle layer along the expected needle pathway.
1% Lidocaine
Procedural Pain score (NRS)
Numeric Rating Scale(NRS) score : from 0 (No pain) to 10 (worst pain imaginable)
Time frame: Immediately after the procedure
At the next outpatient visit, whether the injection site pain(Yes) or not(No)
At the next outpatient visit, subjects asked about injection site pain (Yes / No) after the last injection.
Time frame: 2 weeks
Plan to share: No
This study is completed, as verified in Jan 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Yonsei University